Metabolomic profiling could allow identification of cancer subtypes and precision therapy.
Browsing: Disease Area > Lung
Researchers have demonstrated that individuals with non-small-cell lung cancer who are untreated have a significantly shorter overall survival rate.
Researchers have observed unique visual and behavioral differences among small cell lung cancer tumors; indicating the disease should not be uniformly treated.
Researchers have discovered that lung cancer patients could benefit from adjuvant chemotherapy up to 4 months after surgery.
A recent study has demonstrated that lung cancer patients suffering from depression are more likely to have a decreased tolerance to chemotherapy and lower overall survival.
A pro-metastatic protein interaction has been identified in lung cancer and could present a potential future target.
Researchers have identified new prognostic factors that can be used to predict survival in patients with lung cancer that has spread to the brain.
Researchers have developed a risk prediction model that could be utilized to better predict lung cancer risk in never, light and heavy smokers.
A new study may have identified a novel solution to treating lung cancer, through the use of a glycosylation inhibitor.
Researchers present two case reports that demonstrate the use of intensity modulated radiotherapy for malignant pleural mesothelioma and pediatric pleuropulmonary synovial sarcoma.